You are here
Proof-of-Concept funding has helped to enable the formation of startup companies, attract venture and angel funding, and advance applications for SBIR/STTR funding.
Below are I-POC awardees and their projects.
Enabling the development of new crop varieties to recruit beneficial microbes and improve plant productivity.
Using machine learning to enhance the sensitivity and detecting resolution of bio-molecule structure and composition by using solid-state nanopore technology with advanced two-dimensional materials.
Developing an app with a self-guided program that will help Latinos with limited English proficiency acccess mental health services.
Developing an app that uses sensors for measuring postural sway and for recording environmental fall-risk factors to prevent falls among older adults.
Developing a method to enable discovery and surveillance of antimicrobial resistance.
Next Gen Molecular Pathology
Engineered Tissue Systems
A genetic marker system to reduce variation in soybean cyst nematode resistance within commercial varieties
AmpliMy: Wheelchair Voice Amplifier
A peer support mobile application for friends of emerging adults with alcohol problems
Developing a Soybean Cyst Nematode (SCN) testing service that is faster and provides more precise data than existing solutions.
Company: Soil Diagnostics
Commercializing a Quantitative Pneumatic Otoscope, which uses optical coherence tomography (OTC) to visualize middle ear disease.
Company: Photonicare, which went on to participate in the I-Corps program. The company has received more than $2M in non-dilutive funding from the National Institutes of Health, Food and Drug Administration, and other institutions, including a Phase II SBIR from the NIH to conduct clinical trials of its ClearView device at Children's National Health System in Washington, DC. To learn more, watch this video, produced with the AUTM Better World Project.
Advancing a non-toxic amphotericin toward clinical candidacy by developing a compound with the potential to become a frontline antifungal therapy.
Company: Revolution Medicines, which launched in 2015 with a $45 million investment from Third Rock Ventures.
Developing a high-speed underwater wireless communications system. Professor Singer has received a $150,000 SBIR award to further the technology's development.
Company: OceanComm, which has gone on to receive an SBIR award for further development.
Replacing paper-based music theory instruction with the Harmonia music theory application, which allows musical content to be created, edited, searched, annotated, and automatically graded. Professor Taube has received a $225,000 STTR award to continue developing his prototype.